EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study ( DINE )

Umanath Adhikari, Hoda Gad, Debajyoti Chatterjee, Chintan Malhotra, Sanjay Kumar Bhadada, Rayaz A Malik iD, Ashu Rastogi iD

Journal of the Peripheral Nervous System · 2025-03 · 30 (1)

DOI: 10.1111/jns.70011 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the Peripheral Nervous System, online erschienen am 05.03.2025. Verfasst von Umanath Adhikari und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Glucosides, Benzhydryl Compounds, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

There are currently no FDA‐approved disease‐modifying therapies for diabetic peripheral neuropathy (DPN). We evaluated the effect of the sodium‐glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in Type 2 diabetes mellitus (T2DM) with DPN. Research Design and Methods In this prospective, open‐label, randomised, controlled study, 40 participants with DPN were randomised to receive add‐on 10 mg dapagliflozin OD (Group A) to existing oral antidiabetic drugs (OAD) ( n = 22) or continue OADs as a standard of care (Group B) ( n = 18). Participants underwent assessment of neuropathic symptoms and signs (MNSI), vibration perception threshold (VPT), corneal confocal microscopy (CCM) to quantify corneal nerve fibre density (CNFD), corneal nerve branch density (CNBD) and corneal nerve fibre length (CNFL) and skin biopsy to assess intraepidermal nerve fibre density (IENFD) and plasma markers of oxidative stress at randomisation and after 6 months.

Results

HbA1c decreased in Group A ( p = 0.002) and Group B ( p = 0.003), with no change in weight, body mass index (BMI) or lipids. Total MNSI increased in Group A ( p = 0.01) with no change in Group B ( p = 0.06). IENFD increased significantly in Group A ( p = 0.01) and Group B ( p = 0.01), while CNFD ( p = 0.002), CNBD ( p < 0.001) and CNFL ( p = 0.025) increased in Group A with no change in Group B. There was a significant increase in glutathione peroxidase ( p = 0.02) in Group A with no change in Group B, and a decrease in malondialdehyde in both groups ( p < 0.001).

Conclusions

In participants with T2DM and DPN, dapagliflozin was associated with small nerve fibre regeneration and improvement in markers of oxidative stress. Trial Registration: Clinical Trial Registry India, CRTI Reg. No (CTRI/2022/06/043236); ClinicalTrials.gov Identifier: NCT05162690

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesGlucosidesBenzhydryl CompoundsDiabetes Mellitus, Type 2Nerve FibersSodium-Glucose Transporter 2 InhibitorsNerve RegenerationHumansMaleFemaleMiddle AgedAgedCorneaProspective StudiesHypoglycemic Agents

Stichwörter der Autor:innen

corneal confocal microscopy (CCM)dapagliflozindiabetic peripheral neuropathy (DPN)intraepidermal nerve fibre density (IENFD)

Substanzen

dapagliflozinGlucosidesBenzhydryl CompoundsSodium-Glucose Transporter 2 InhibitorsHypoglycemic Agents

Autor:innen und Institutionen

  • Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Medicine, Weill Cornell Medicine-Qatar, Doha, Qatar.
  • Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Department of Ophthalmology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

ORCID-Profile: Rayaz A Malik, Ashu Rastogi

Zitieren

APA

Adhikari, U., Gad, H., Chatterjee, D., Malhotra, C., Bhadada, S. K., Malik, R. A., & Rastogi, A. (2025). Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study ( DINE ). Journal of the Peripheral Nervous System, 30(1). https://doi.org/10.1111/jns.70011

Vancouver

Adhikari U, Gad H, Chatterjee D, Malhotra C, Bhadada SK, Malik RA, et al. Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study ( DINE ). Journal of the Peripheral Nervous System. 2025;30(1). doi:10.1111/jns.70011

BibTeX
@article{Adhikari2025,
  author = {Adhikari, Umanath and Gad, Hoda and Chatterjee, Debajyoti and Malhotra, Chintan and Bhadada, Sanjay Kumar and Malik, Rayaz A and Rastogi, Ashu},
  title = {Dapagliflozin for Small Nerve Fibre Regeneration in Diabetic Peripheral Neuropathy: A Randomised Controlled Study ( DINE )},
  journal = {Journal of the Peripheral Nervous System},
  year = {2025},
  volume = {30},
  number = {1},
  doi = {10.1111/jns.70011}
}
Kostenlos starten →